<DOC>
	<DOCNO>NCT00941733</DOCNO>
	<brief_summary>This prospective , multi-center , randomize ( 2:1 ) trial symptomatic patient critical limb ischemia ( CLI ) secondary atherosclerotic lesion ( stenotic occlude ) infrapopliteal vessel . Patients undergo percutaneous transluminal endovascular procedure either IN.PACT Amphirion™ drug elute balloon standard ( Percutaneous Transluminal Angioplasty ) PTA balloon . Patients follow pre-study , post-study , follow-up evaluation .</brief_summary>
	<brief_title>Study IN.PACT Amphirion™ Drug Eluting Balloon vs. Standard PTA Treatment Below Knee Critical Limb Ischemia</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<criteria>General Inclusion Criteria Age ≥18 year ≤85 year Patient patient 's legal representative inform nature study , agree participate sign Ethical Committee approve consent form Female patient childbearing potential negative pregnancy test ≤7 day procedure willing use reliable method birth control duration study participation Patient document chronic Critical Limb Ischemia ( CLI ) target limb prior study procedure Rutherford Category 4 , 5 6 Life expectancy &gt; 1 year Investigator 's opinion General Angiographic Inclusion Criteria Reference vessel ( ) diameter 2 4 mm Single multiple lesion ≥70 % diameter stenosis ( DS ) different lengths one main afferent crural vessel include tibioperoneal trunk At least one non occlude crural vessel angiographically document runoff foot either direct collateral Angiographic Inclusion Criteria Late Lumen Loss ( LLL ) assessment Angiotarget lesion ( TL ) one identifiable single solitary series multiple adjacent lesion diameter stenosis ( DS ) ≥70 % cumulative length ≤100 mm cover single IN.PACT Amphirion™ ( 10 mm balloon land zone edge mandatory ) Angiotarget lesion ( TL ) lesion vessel ( one AngioTL per patient allow ) General Exclusion Criteria Patient unwilling unlikely comply FollowUp schedule Planned major index limb amputation General Angiographic Exclusion Criteria Lesion / occlusion locate extend popliteal artery ankle joint space Inflow lesion occlusion ipsilateral Iliac , Superficial Femoral Artery ( SFA ) , popliteal artery length ≥15 cm Significant ( ≥50 % DS ) inflow lesion occlusion ipsilateral Iliac , Superficial Femoral Artery ( SFA ) popliteal artery leave untreated Previously implant stent target lesion ( ) Aneurysm target vessel Acute thrombus target limb General Procedural Exclusion Criteria Failure obtain &lt; 30 % residual stenosis preexisting , hemodynamically significant ( ≥50 % diameter stenosis ( DS ) &lt; 15 cm length ) inflow lesion ipsilateral iliac , SFA popliteal artery . No Drug Eluting Stents ( DES ) / Drug Eluting Balloon ( DEB ) allow treatment inflow lesion . Failure cross TL 0.014 '' guide wire Use alternative therapy , e.g . atherectomy , cut balloon , laser , radiation therapy , DES part index procedure ANGIOGRAPHIC cohort General Glomerular Filtration Rate ( GFR ) &lt; 30 ml/min except patient renal end stage disease chronic haemodialysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>BTK</keyword>
	<keyword>CLI</keyword>
	<keyword>PTA</keyword>
</DOC>